Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
about
Update on Inflammatory Biomarkers and Treatments in Ischemic StrokeNeuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and releaseNeuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.Impact of baseline characteristics on outcomes of carotid artery stenting in acute ischemic stroke patients.Purines: forgotten mediators in traumatic brain injury.Enrollment Yield and Reasons for Screen Failure in a Large Prehospital Stroke Trial.A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke.Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke.Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke.Neuroprotection in stroke: the importance of collaboration and reproducibility.The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature.The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders.What's new in stroke? Phase III randomized clinical trials of 2012-2014.ABCG2 c.421C>A is Associated with Outcomes Following Severe Traumatic Brain Injury.Current disease modifying approaches to treat Parkinson's disease.Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke.Effect of waivers of consent on recruitment in acute stroke trials: A systematic reviewStroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014.Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.Urate as a Marker of Risk and Progression of Neurodegenerative Disease.Targeting urate to reduce oxidative stress in Parkinson disease.An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke.Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: a target of uric acid treatment.Uric acid for acute stroke: fantasy or reality?Suitable Concentrations of Uric Acid Can Reduce Cell Death in Models of OGD and Cerebral Ischemia-Reperfusion Injury.Sex-dependent effects of uric acid on cerebral microbleed: a cross-sectional study in the general population.Recent pharmacological advances in the management of gout.The pharmacogenomics of severe traumatic brain injury.Uric acid improves glucose-driven oxidative stress in human ischemic stroke.Uric Acid Is Protective After Cerebral Ischemia/Reperfusion in Hyperglycemic Mice.Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy.Sex differences in the impact of acute stroke treatment in a population-based study: a sex-specific propensity score approach.Association between Serum Uric Acid Level and Carotid Atherosclerosis in Chinese Individuals Aged 75 Years or Older: A Hospital-Based Case-Control Study.Targeting NMDA receptors in stroke: new hope in neuroprotection.High uric acid level predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography: Meta-analysis and systematic review.What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?Neuroprotectants in the Era of Reperfusion Therapy.Clinical and Basic Evaluation of the Prognostic Value of Uric Acid in Traumatic Brain Injury.Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
P2860
Q28078744-724ECEA7-2DAD-4752-8135-AC567ED0831EQ28393646-74842309-235B-4A41-9E1C-0E54EEA70F53Q36256704-AC4715EF-065A-4234-A8E4-0140480206DFQ36763580-BF976EE7-A8EA-4F5C-98B4-584DFCFD75AAQ36788533-ED822B0A-644F-455F-8AE9-97FAAF7998EFQ37008738-FBCA453E-A2E5-4F67-9EDF-DFE190C3DFEBQ37449324-AB47EA92-B71F-45C1-A8D8-E7C095CC7271Q38366399-6E4D6983-8B6B-4D39-8207-E88076674B3BQ38368304-4C2BE7C2-4CE5-4128-A1FD-03417008585DQ38370165-F4D71FE3-1733-4393-94DD-F4A3E0B69835Q38378478-AE87F785-6B13-41FB-98BB-94F9DA6671BFQ38522643-75DC9082-2C99-4A64-8277-68F39E790DD8Q38547886-4E45591D-D30D-432E-9066-29AA20B743D9Q38651433-0D1AA39E-7135-4ECA-858C-A01D778144B6Q38652153-5570E4FE-7067-44D4-94E0-609732385952Q38681592-2AC44493-A098-411A-9E6E-37849DDD3443Q38786616-6B2EB8BD-F516-41A0-8218-D6464BD176E8Q38825181-EA76F734-B5E1-482F-8179-DDC201FE1C6FQ39011186-564C35A5-71DB-4547-BF8C-59E982AE6147Q39013294-991165C0-46EE-4793-9AD1-C97F4226E76FQ39044143-2F42103D-64D3-4933-8C46-B5A39A7BE3ACQ39379023-641B72D7-CFD4-4F5A-BEEC-B9AE7340C35AQ40523644-8D35F015-ABED-4136-A1A3-AAD75298FF68Q42472220-D4D064D5-EA96-4B41-9052-D83A992CAE60Q42756732-09A879B5-3F63-4AD4-BCED-2D3AC6115620Q46481238-3320064B-8FA1-47D2-AE76-E7D6F172FEA0Q47303137-D6950DF7-AE8B-4907-8014-B111119AD4CCQ47919692-0B053A20-9C52-4E71-8677-A39452824038Q48034526-FF6E892E-3C3E-4E68-A7BF-16F87BFC836EQ48357007-0F292DBD-7B98-4925-A788-46F16601E41EQ48393879-42D11AFF-1F0E-4CE5-8517-DCBC15FBA810Q49079114-90FB61A1-8B4F-4EF4-A5C8-A21BE3DFB79CQ49958817-A171614D-CBF7-42B7-AB86-8A2CA48DDDB5Q51759101-9BED86A8-9620-41D0-A95D-103450679DE9Q52657620-43534E34-1FD4-430B-9547-D40728655D4AQ55027128-1DA41DF9-E73F-42CA-8EE9-0E9F09C0FDBEQ55154901-E42BC3C0-EB4B-4C6F-9CD8-0D9A86CC174DQ55261150-CC6C1438-0C01-4477-B44B-EBF6CB5A2618Q55656918-AA69FABF-F4DA-40E5-ACC9-790E91CE1CC3Q58116221-900A22DB-5CC7-4C9D-8C78-40E241C0031B
P2860
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Safety and efficacy of uric ac ...... double-blind phase 2b/3 trial.
@en
Safety and efficacy of uric ac ...... double-blind phase 2b/3 trial.
@nl
type
label
Safety and efficacy of uric ac ...... double-blind phase 2b/3 trial.
@en
Safety and efficacy of uric ac ...... double-blind phase 2b/3 trial.
@nl
prefLabel
Safety and efficacy of uric ac ...... double-blind phase 2b/3 trial.
@en
Safety and efficacy of uric ac ...... double-blind phase 2b/3 trial.
@nl
P2093
P50
P1433
P1476
Safety and efficacy of uric ac ...... double-blind phase 2b/3 trial.
@en
P2093
Anna M Planas
David Cánovas
Jaime Gállego
Joan Martí-Fábregas
Juan Arenillas
Jurek Krupinski
Laura Oleaga
Mar Castellanos
Meritxell Gomis
Ramón Deulofeu
P304
P356
10.1016/S1474-4422(14)70054-7
P577
2014-04-02T00:00:00Z